FR2901137B1 - Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient. - Google Patents

Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient.

Info

Publication number
FR2901137B1
FR2901137B1 FR0604489A FR0604489A FR2901137B1 FR 2901137 B1 FR2901137 B1 FR 2901137B1 FR 0604489 A FR0604489 A FR 0604489A FR 0604489 A FR0604489 A FR 0604489A FR 2901137 B1 FR2901137 B1 FR 2901137B1
Authority
FR
France
Prior art keywords
proteasic
quay
vitamins
minerals
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0604489A
Other languages
English (en)
Other versions
FR2901137A1 (fr
Inventor
Dit Bon Michel Betend
Georges Bruttmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0604489A priority Critical patent/FR2901137B1/fr
Publication of FR2901137A1 publication Critical patent/FR2901137A1/fr
Application granted granted Critical
Publication of FR2901137B1 publication Critical patent/FR2901137B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/57Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/142Amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0604489A 2006-05-19 2006-05-19 Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient. Expired - Fee Related FR2901137B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0604489A FR2901137B1 (fr) 2006-05-19 2006-05-19 Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604489A FR2901137B1 (fr) 2006-05-19 2006-05-19 Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient.

Publications (2)

Publication Number Publication Date
FR2901137A1 FR2901137A1 (fr) 2007-11-23
FR2901137B1 true FR2901137B1 (fr) 2013-01-25

Family

ID=37396006

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0604489A Expired - Fee Related FR2901137B1 (fr) 2006-05-19 2006-05-19 Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient.

Country Status (1)

Country Link
FR (1) FR2901137B1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939044B1 (fr) * 2008-11-28 2010-12-31 Dit Bon Michel Betend Nouvelles formulations a base de lyophilisats de lait d'anesse et d'inhibiteurs de proteases humaines,indiquees dans l'intolerance au lait,l'inflammation allergique et infectieuse
FR2947454B1 (fr) * 2009-07-02 2011-09-02 Dit Bon Michel Betend Innovation destinee a l'homme et l'animal a base d'inhibiteurs naturels des proteases humaines associes a des plantes medicinales, indiquees dans toutes les pathologies
BE1020496A3 (fr) 2012-02-10 2013-11-05 Ovogenics Sa Composition anti-inflammatoire pour moduler la reponse cellulaire des neutrophiles et des eosinophiles.
CN110563837B (zh) * 2019-08-01 2021-07-30 华中农业大学 从鸡蛋清中高效提取卵类黏蛋白的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356426A1 (fr) * 1976-06-29 1978-01-27 Truffier Jean Claude Fraction ovomucoide du blanc de l'oeuf de caille, ayant des proprietes antiproteasiques
DE10064704A1 (de) * 2000-02-15 2001-08-16 Goossens Peter Futter-oder Nahrungsmittelergänzungszusatz
FR2813531B1 (fr) * 2000-09-06 2003-02-14 Medibrevex Formes galeniques d'oligoelements incorpores dans un excipient biologiquement actif d'homogenat d'oeufs de caille et leur procede de fabrication
FR2836379B1 (fr) * 2002-02-28 2007-06-01 Dit Bon Michel Betend Formes galeniques solides de medicaments homeopathiques, dont les allergenes ou antigenes, en dilutions homeopathiques pour preparation extemporanee pour un seul individu pour administration sublinguale

Also Published As

Publication number Publication date
FR2901137A1 (fr) 2007-11-23

Similar Documents

Publication Publication Date Title
USD613400S1 (en) Overcap for injector
ITMI20042393A1 (it) Procedimento per la fabbricazione di un componente a semiconduttore nonche' un componente a semiconduttore in particolare un sensore a membrana
HRP20080069T3 (en) Avian e. coli vaccine for the protection against colibacillosis
NO2014005I1 (no) olodaterol, syreaddisjonssalter og farmakologisk akseptable syrer derav
ECSP10010265A (es) Sales farmaceuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8 dihidro-9h-purin-9-il)propil](3-morfolin-4 ilpropil)amino]metil}fenil)
EP2455462A3 (fr) Variantes de lipase pour utilisation pharmaceutique
ITTO990973A0 (it) Valvola di ritegno per linee medicali di infusione e simili.
ITTO990974A0 (it) Valvola di ritegno per linee medicali di infusione e simili.
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
GB2433889B (en) Treatment of gastrointestinal and other disorders with a buffered admixture of vitamins, minerals and amino acids
CY1110170T1 (el) Ν-καρβαμοϋλμεθυλ-4(-r)-φαινυλ-2-πυρρολιδινονη, μεθοδος παρασκευης της και φαρμακευτικη χρηση αυτης
AR063538A1 (es) Tratamiento de la enfermedad de parkinson
DE602005021475D1 (de) Magenresistente pharmazeutische dosierform mit n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutaminsäure (lk-423)
FR2901137B1 (fr) Nouvelles formes galeniques d'inhibiteurs naturels des enzymes proteasiques, extraits d'oeuf de caille, associes a des vitamines ou/et a des mineraux, acides amines incorpores dans un excipient.
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
WO2009019835A1 (fr) Médicament liquide contenant un mélange d'extrait pharmacologique brut
WO2009107971A3 (fr) Polypeptide spécifiquement couplé à la phosphatidylsérine et utilisation de celui-ci
WO2008021048A3 (fr) Procédés et compositions fondés sur l'adp-ribosyltransférase
ITMI20050578A1 (it) Procedimento e impianto per la produzione di farine animali a migliorata disponibilita' di amminoacidi
WO2001054707A3 (fr) Utilisation d'au moins un inhibiteur d'aminopeptidase
EA200500958A1 (ru) Дейтерированные производные катехоламина, а также лекарственные средства, содержащие эти соединения
ITRM20030596A1 (it) Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
ITMI20030972A1 (it) Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
DK1763515T3 (da) 4-Triflourmethoxyphenoxybenzen-4'-sulfonsyrer, fremgangsmåde til deres fremstilling og anvendelse i lægemidler
DZ3461A1 (fr) Pro-medicaments d acides amines excitateurs.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20210105

IC Decision of the director general to declare irreceivable or to reject an appeal

Effective date: 20220503